twistbioscience.com (TWST): Operatsion rentabellik

Twist Bioscience Inc (TWST) kompaniyasining korporativ logotipi

Twist Bioscience (TWST) genomika va raqamli arxivlar segmentida o'z tijorat mavjudligini faol ravishda kengtirmoqda. Operatsion rentabellik ushbu o'sishni baholash imkonini beradi, bunda -28.80 qiymati metrika darajasini ifodalaydi. Kompaniya bioinzheneriyaga investitsiya kiritish orqali chiplarda DNK sintezi bo'yicha yetakchilik qilmoqda. Kremniy texnologiyalaridan foydalanish past xarajatlar evaziga ommaviy ishlab chiqarishni yo'lga qo'yib, tibbiyot va qishloq xo'jaligi sektorlari uchun qiymat yaratmoqda.

TWST: twistbioscience.com Sotuvning operatsion marjasi 04.07.2022 - 19.11.2026

Twist Bioscience, Inc. (TWST) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:TWST, Twist Bioscience Corp
twistbioscience.com brendining mahsuloti

Uzoq muddatli investitsiyalar xarajatlarni boshqarish samaradorligi ustidan qat'iy nazoratni talab qiladi. Twist Bioscience (TWST) kompaniyasining o'ziga xosligi sintetik DNKga bo'lgan barqaror talab va ma'lumotlarni saqlash sohasidagi kapital talab qiluvchi ishlanmalar o'rtasidagi muvozanatda namoyon bo'ladi. Operatsion marjaning o'zgarishlarini tahlil qilish orqali investor soliqlar va foizlardan oldingi asosiy operatsiyalardan olingan foyda ulushini baholaydi. Ushbu ko'rsatkich biznesning daromadni operatsion foydaga aylantirish qobiliyatini o'lchaydi. Ijobiy dinamika modelning yuqori R&D xarajatlariga nisbatan barqarorligini tasdiqlaydi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|TXG (10xgenomics.com) - Operatsion marja|NTLA (Intellia Therapeutics, Inc.) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Stoke Corp (STOK)|Operatsion faoliyat rentabelligi BioLife|Operatsion marja WVE (Wave Life Sciences Ltd)|MAZE: Operatsion foyda bo'yicha sotuv rentabelligi|Sionna Therapeutics, Inc. - Operatsion marja|Operatsion foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik